The data obtained from TCGA and GTEx demonstrated that GARS was overexpressed in breast cancer tissues compared with tumor-adjacent tissues and healthy tissues, which is consistent with our hospital results (Fig. 3A, P < 0.0001). The gene discussed is GARS1; the disease is breast cancer.